A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells

Aberrant androgen signaling drives prostate cancer and is targeted by drugs that diminish androgen production or impede androgen–androgen receptor (AR) interaction. Clinical resistance arises from AR overexpression or ligand-independent constitutive activation, suggesting that complete AR eliminatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Auvin, Serge, Öztürk, Harun, Abaci, Yusuf T, Mautino, Gisele, Meyer-Losic, Florence, Jollivet, Florence, Bashir, Tarig, de Thé, Hugues, Sahin, Umut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703138/
https://www.ncbi.nlm.nih.gov/pubmed/31431473
http://dx.doi.org/10.26508/lsa.201800213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703138/
https://www.ncbi.nlm.nih.gov/pubmed/31431473
http://dx.doi.org/10.26508/lsa.201800213

Ejemplares similares